Posted by ABMN Staff on Jan 29th, 2025
CVS Health (NYSE:CVS – Get Free Report) had its price objective upped by analysts at Evercore ISI from $60.00 to $65.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “outperform”...
More of this article »